Press ReleaseAIMHI_wpuser2024-08-29T11:16:30+00:00

Press Release

Press Release

AIM-HI Women’s Venture Competition Sponsor: Microsoft

AIMHI_wpuser2024-08-13T07:28:09+00:00December 15, 2020|Press Release|

Tvardi Therapeutics Awarded “Most Promising” Company at the 2020 Texas Life Science Forum

AIMHI_wpuser2024-08-13T07:26:28+00:00November 20, 2020|Press Release|

Oncoheroes Biosciences’ Pediatric Cancer Drug Candidate Receives Orphan Drug Designation

AIMHI_wpuser2024-08-13T07:24:51+00:00October 14, 2020|Press Release|

Congratulations to our Top Two Finalists and the People’s Choice Award Winner!

AIMHI_wpuser2024-08-13T07:21:27+00:00September 29, 2020|Press Release|

Support Women Scientist-Entrepreneurs in Celebration of the Women’s Equality Day

AIMHI_wpuser2024-08-13T07:18:20+00:00August 25, 2020|Press Release|

AIM-HI Portfolio Company Profile: Rasio Therapeutics

AIMHI_wpuser2024-08-13T07:15:27+00:00August 10, 2020|Press Release|

Previous 789 Next

AIMhi

AIM-HI Accelerator Fund is a 501(c)(3) tax-exempt nonprofit organization.

Tax ID #: 82-4322538

Address:

5515 Security Lane, Suite 1105
Rockville, MD 20852

Email:

info@aim-hiaccelerator.org

Phone:

1-800-321-CURE (2873)

what we do

Copyright © AIM-HI 2024 All Rights Reserved

AIMhi

AIM-HI Accelerator Fund is a 501(c)(3) tax-exempt nonprofit organization.

Tax ID #: 82-4322538

Copyright © AIM-HI 2024 All Rights Reserved